Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating Activities:    
Net loss $ (3,022) $ (205)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization [note 4] 86 56
Deferred income tax (recovery) [note 2 and note 4]   (124)
Stock-based compensation [note 8 [c] and note 8 [d]] 181  
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 217  
Accounts payable 207 149
Accrued liabilities other 94 113
Accrued clinical liabilities (103)  
Accrued compensation 134  
Lease obligation (27)  
Net cash used in operating activities (2,233) (11)
Financing Activities:    
Stockholder loans   20
Proceeds from purchase agreement with Lincoln Park Capital, net of issuance costs 1,105  
Net cash provided by financing activities 1,105 20
Investing Activities:    
Proceeds on disposal of assets 10  
Net cash provided by investing activities 10  
Effect of exchange rate changes on cash (1)  
Net increase (decrease) in cash, cash equivalents and restricted cash (1,119) 9
Cash, cash equivalents and restricted cash at beginning of year 5,556 15
Cash, cash equivalents and restricted cash at end of year $ 4,437 $ 24